US Patent 7473695 4-imidazolin-2-one compounds
Patent 7473695 was granted and assigned to Mitsubishi Tanabe Pharma on January, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+78 characters)
Article
Patent abstract
The present invention relates to a compound of the formula [I]:
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07473695 4-imidazolin-2-one compounds US Patent 7473695 4-imidazolin-2-one compounds
Infobox
Patent Number
0747369500
Patent Number
747369500
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074736950
Date of Patent
January 6, 2009
0Patent Application Number
108272940
Date Filed
April 20, 2004
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074736950
Date of Patent
January 6, 2009
0Patent Application Number
108272940
Date Filed
April 20, 2004
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07473695 4-imidazolin-2-one compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07473695
Date of patent
January 6, 2009
Patent application number
10827294
Date Filed
April 20, 2004
Patent primary examiner
Find more entities like US Patent 7473695 4-imidazolin-2-one compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
